Mikihiro Yunoki

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Transfusion

Vox sanguinis

Biologics : targets & therapy

Journal of medical virology

Osaka University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Osaka University

Japan

PHD

Publications

Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Tatsuo Shioda
Anti-monkeypox virus-neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan. Vox sanguinis (2024)
Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Tatsuo Shioda
Anti-monkeypox virus-neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan. Vox sanguinis 119 (8) (2024)
Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Tatsuo Shioda
Decline in intravenous immunoglobulin titer against influenza virus A/H2N2 derived from donors in Japan. Journal of medical virology (2023)
Mikihiro Yunoki, Risa Nakagawa, Hiroyuki Onodera, Jun Tanaka, Katsuyuki Haino
Long-term monitoring of antibody titers against microorganisms in human intravenous immunoglobulin lots derived from healthy donors in Japan manufactured during 1998-2018. Transfusion 62 (7) (2022)
Ritsuko Kubota-Koketsu, Mikihiro Yunoki, Yoshinobu Okuno, Kazuyoshi Ikuta
Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7. Biologics : targets & therapy 15 (2021)
Takamasa Inoue, Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Tatsuo Shioda
Assessment of the potentially decreased neutralizing activities of intravenous immunoglobulin against future coronavirus variants. Transfusion 61 (8) (2021)
Motonori Ikegawa, Shinichi Ohashi, Takao Minagi, Hiroko Okamoto, Mikihiro Yunoki
Screening for parvovirus B19 antigen through chemiluminescent enzyme immunoassay is equivalent to B19 nucleic acid amplification test-based screening of pooled plasma. Transfusion 61 (8) (2021)
Ritsuko Kubota-Koketsu, Yutaka Terada, Mikihiro Yunoki, Tadahiro Sasaki, Emi E Nakayama, Wataru Kamitani, Tatsuo Shioda
Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan. Transfusion 61 (2) (2020)
Hiroyuki Onodera, Risa Nakagawa, Hitoshi Nakagawa, Takeru Urayama, Katsuyuki Haino, Mikihiro Yunoki
Long-term monitoring of virus antibody titers in human intravenous immunoglobulin lots derived from donors in Japan. Transfusion 58 (11) (2018)

Mikihiro Yunoki.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mikihiro Yunoki